Literature DB >> 18212097

Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

Aki Okazaki1, Matthew B Avison.   

Abstract

A divergently oriented ampR has been located upstream of blaL2 in Stenotrophomonas maltophilia. AmpR is necessary for L1 and L2 beta-lactamase induction in response to beta-lactam challenge, and activation of AmpR is sufficient to induce L1 and L2 production. L1 induction requires more activation of AmpR than does L2 induction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212097      PMCID: PMC2292540          DOI: 10.1128/AAC.01485-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

Authors:  M B Avison; C S Higgins; C J von Heldreich; P M Bennett; T R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Determination of minimum inhibitory concentrations.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

3.  Constitutive expression of a chromosomal class A (BJM group 2) beta-lactamase in Xanthomonas campestris.

Authors:  Shu-Fen Weng; Juey-Wen Lin; Chih-Hung Chen; Yih-Yuan Chen; Yi-Hsuan Tseng; Yi-Hsiung Tseng
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.

Authors:  Aki Okazaki; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

5.  A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia.

Authors:  M B Avison; C J von Heldreich; C S Higgins; P M Bennett; T R Walsh
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

Review 6.  Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae.

Authors:  N D Hanson; C C Sanders
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

7.  Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.

Authors:  Niels Bagge; Oana Ciofu; Morten Hentzer; Joan I A Campbell; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia.

Authors:  Matthew B Avison; Catherine S Higgins; Peter J Ford; Charlotte J von Heldreich; Timothy R Walsh; Peter M Bennett
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

9.  Aeromonas hydrophila AmpH and CepH beta-lactamases: derepressed expression in mutants of Escherichia coli lacking creB.

Authors:  M B Avison; P Niumsup; T R Walsh; P M Bennett
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

10.  Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of beta-lactamase expression in Aeromonas spp.

Authors:  Pannika Niumsup; Alan M Simm; Kurshid Nurmahomed; Timothy R Walsh; Peter M Bennett; Matthew B Avison
Journal:  J Antimicrob Chemother       Date:  2003-05-13       Impact factor: 5.790

View more
  41 in total

Review 1.  The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Bioorg Chem       Date:  2014-06-04       Impact factor: 5.275

Review 2.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

3.  Disruption of mpl Activates β-Lactamase Production in Stenotrophomonas maltophilia and Pseudomonas aeruginosa Clinical Isolates.

Authors:  Karina Calvopiña; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 4.  Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance.

Authors:  David A Dik; Jed F Fisher; Shahriar Mobashery
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

5.  Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.

Authors:  Virginia C Gould; Aki Okazaki; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia.

Authors:  Yi-Wei Huang; Cheng-Wen Lin; Rouh-Mei Hu; Yu-Tzu Lin; Tung-Ching Chung; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

7.  Introduction of an AmpR-L2 intergenic segment attenuates the induced beta-lactamase activity of Stenotrophomonas maltophilia.

Authors:  Y-C Chang; Y-W Huang; K-H Chiang; T-C Yang; T-C Chung
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-16       Impact factor: 3.267

8.  Genome sequence of Stenotrophomonas maltophilia S028, an isolate harboring the AmpR-L2 resistance module.

Authors:  Shiping Song; Xitong Yuan; Shiwei Liu; Ning Zhang; Yufei Wang; Yuehua Ke; Jie Xu; Liuyu Huang; Zeliang Chen; Yan Li
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

9.  Imipenem-resistant Gram-negative bacterial isolates carried by persons upon medical examination in Korea.

Authors:  So Yeon Kim; Sang Yop Shin; Ji-Young Rhee; Kwan Soo Ko
Journal:  J Microbiol       Date:  2017-07-18       Impact factor: 3.422

10.  Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.

Authors:  Karina Calvopiña; Klaus-Daniel Umland; Anna M Rydzik; Philip Hinchliffe; Jürgen Brem; James Spencer; Christopher J Schofield; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.